Dataset from Pilot Study Of Novel Combination Of Maraviroc + Atazanavir/Ritonavir vs. Atazanavir/Ritonavir + Emtricitabine/Tenofovir For The Treatment Of Naïve HIV-Infected Patients With R5 HIV-1

This is a pilot study to examine if the novel treatment regimen maraviroc plus boosted
atazanavir can be expected to be safe and efficacious in treatment naive HIV infected
patients. Based on the results from this study, a confirmatory phase 3 study may be
conducted.